The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
In older men with low testosterone, one year of testosterone treatment improved bone density and corrected anemia of both known and unknown causes, but also increased the volume of coronary artery plaque, according to results reported from the Testosterone Trials (T Trials).
Atlantis Healthcare, the global leader in patient self-management and behavior change programs, releases its latest white paper, Chronic Illness Experience in Children and Adolescents: Exploring Challenges and Solutions. This is the third paper in a series focusing on self-management in chronic illness.
Intensix, developer of a real-time predictive analytics platform for early detection of patient deterioration in the ICU and high acuity departments of hospitals, has announced the positive results of a clinical study of the effectiveness of the Intensix platform in detecting and predicting sepsis in the ICU.
Short Course to Highlight Intracellular Cytokine Detection Assay in Adoptive Cell Therapy Trials and Poster to Highlight Metaproteomic Analysis of Gut Microbiome in Enfants
Prescription pain medications provided by “physicians in the months after an emergency department visit are necessary for long-term opioid use to take hold,” according to a new study in the Feb. 16th edition of The New England Journal of Medicine (NEJM).
Boehringer Ingelheim Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms.
A new method for screening women with dense breast tissue may potentially save thousands of lives by detecting breast cancer four to six years earlier than mammographic technology.
Adapt Pharma Canada has announced that 22,000 kits of NARCAN® naloxone Nasal Spray have been shipped in the past six months to more than 75 first responder agencies – primarily law enforcement agencies.
Chicagoland families and providers with children on the autism spectrum are invited to enroll in a groundbreaking social skills study.